Cryoport, Inc. (CYRX) Stock

Industrials · Integrated Freight & Logistics · Member of Other US Stocks

Cryoport, Inc. (CYRX) closed at USD 16.64 on 2026-10-14, a change of +84.1 % over the past year, with a market capitalization of USD 864.58M.

Cryoport, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Cryoport, Inc. key figures

Previous close

USD 16.64 (2026-10-14)

1-year change

+84.1 %

Market cap

USD 864.58M

Enterprise value

USD 746.18M

P/E ratio (trailing)

-20.82

P/E ratio (forward)

-25.73

EPS (trailing)

-0.82

EPS (forward)

-0.66

PEG ratio

62.13

Price to book

1.95

Revenue growth

7.7 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

3.97

Employees

684

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Cryoport, Inc.

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Cryoport, Inc. and compare it with other stocks.